Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-11

Clinical Trial Update: Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining apatinib as first-line therapy in elderly patients with locally advanced or metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Bengbu Medical University | Conditions: Gastric Cancer, Apatinib | Phase 2 | Status: UNKNOWN